Facebook Twitter LinkedIn Google Plus RSS

NPS Pharmaceuticals announces public stock offering

By ,

NPS Pharmaceuticals Inc., of Bedminster, on Monday announced it has begun an underwritten public offering of 6 million shares of its common stock.

According to an announcement, NPS intends to grant its a 30-day option to purchase up to 900,000 additional shares of its common stock to cover over-allotments, if any. The offering is subject to market and other conditions.

You May Have Missed...

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy